The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression

Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

NCT05711940 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Psilocybin for Treatment-Resistant Depression

NCT06230757 ·Status: COMPLETED ·Phase: PHASE2

Effects of Psilocybin in Major Depressive Disorder

NCT03181529 ·Status: COMPLETED ·Phase: PHASE2

Psilocybin for Major Depressive Disorder (MDD)

NCT06308653 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

NCT05624268 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression

NCT04670081 ·Status: COMPLETED ·Phase: PHASE2

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD

NCT05381974 ·Status: WITHDRAWN ·Phase: PHASE2

Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)

NCT04519957 ·Status: COMPLETED

Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression

NCT07183748 ·Status: RECRUITING ·Phase: PHASE2

Psilocybin for Treatment-Resistant Depression in Autism

NCT06731621 ·Status: RECRUITING ·Phase: PHASE1

Psilocybin for Treatment-Resistant Depression

NCT05029466 ·Status: COMPLETED ·Phase: PHASE2

Psilocybin for Major Depressive Disorder

NCT05675800 ·Status: WITHDRAWN ·Phase: PHASE2

Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept

NCT03715127 ·Status: COMPLETED ·Phase: PHASE2

Psilocybin and Depression

NCT03380442 ·Status: UNKNOWN ·Phase: PHASE2

Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder

NCT04620759 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397 ·Status: RECRUITING ·Phase: PHASE3

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

NCT07226232 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Psilocybin Versus Ketamine in Treatment-Resistant Depression

NCT05383313 ·Status: UNKNOWN ·Phase: PHASE2

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder

NCT06247839 ·Status: RECRUITING ·Phase: PHASE3

Measurement of Serum Inflammatory Markers in Patients Treatment-resistant Depression Given Psilocybin

NCT07164755 ·Status: ACTIVE_NOT_RECRUITING

A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder

NCT05733546 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

NCT06341426 ·Status: RECRUITING ·Phase: PHASE2

Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

NCT03554174 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

BPL-003 Efficacy and Safety in Treatment Resistant Depression

NCT05870540 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression

NCT07211438 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2